Key Points
- Recalled Product: 5,765 “Kushy Punch” vape cartridges produced by Exclusive Brands.
- Test Results: Found to contain MCT oil.
- Health Risks: Inhalation of MCT oil can cause pneumonia, bronchitis, and other serious illnesses.
- Regulatory Background: CRA banned the use of MCT oil in cannabis vapes in October 2024.
- Previous Cases: Earlier this month, CRA recalled more than 26,000 “Motor City Cannacarts” and “RIPZ” vapes made by Warren-based Sky Cannabis.
- Consumer Alert: Those who purchased “Pineapple Jealousy” Kushy Punch vapes should check the recall bulletin; affected products may be returned or exchanged.
2Firsts, August 27, 2025 —— According to WKFR, the Michigan Cannabis Regulatory Agency (CRA) announced on August 27 the recall of 5,765 “Kushy Punch” brand cannabis vape cartridges produced by Ann Arbor company Exclusive Brands, after an investigation found the products contained medium-chain triglyceride (MCT) oil, which is banned in cannabis vaping products.
The CRA officially prohibited the use of MCT oil in cannabis vapes in October 2024. However, recent testing revealed that some companies continue to ignore the regulation. The agency noted that although MCT oil is widely used and safe in food, inhaling it into the lungs can cause inflammation and lead to more severe illnesses, including pneumonia and bronchitis.
This is not the first recall. Earlier this month, the CRA recalled more than 26,000 “Motor City Cannacarts” and “RIPZ” brand vape cartridges produced by Warren-based Sky Cannabis for the same reason.
Regulators urged consumers, especially those who purchased the “Pineapple Jealousy” flavor Kushy Punch vapes, to immediately consult the recall bulletin to determine if their products are affected. Eligible products can be returned or exchanged according to store policy. Consumers who have experienced adverse effects are advised to seek medical attention and report symptoms to their healthcare provider.
The CRA emphasized it will continue strict oversight and testing of cannabis vaping products in circulation to safeguard public health.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
